These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2153029)

  • 1. Colony-stimulating factor-1 receptor.
    Sherr CJ
    Blood; 1990 Jan; 75(1):1-12. PubMed ID: 2153029
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the CSF-1 receptor gene (C-fms) in cell transformation.
    Sherr CJ
    Leukemia; 1988 Dec; 2(12 Suppl):132S-142S. PubMed ID: 2848991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor.
    Sherr CJ; Rettenmier CW; Roussel MF
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 1():521-30. PubMed ID: 2855492
    [No Abstract]   [Full Text] [Related]  

  • 4. Raf-1: a kinase currently without a cause but not lacking in effects.
    Li P; Wood K; Mamon H; Haser W; Roberts T
    Cell; 1991 Feb; 64(3):479-82. PubMed ID: 1846778
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor.
    Roussel MF; Transy C; Kato JY; Reinherz EL; Sherr CJ
    Mol Cell Biol; 1990 May; 10(5):2407-12. PubMed ID: 1691441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor receptors and cell transformation.
    Sherr CJ
    Mol Biol Med; 1987 Feb; 4(1):1-10. PubMed ID: 3039289
    [No Abstract]   [Full Text] [Related]  

  • 7. Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains.
    Roussel MF; Downing JR; Sherr CJ
    Oncogene; 1990 Jan; 5(1):25-30. PubMed ID: 2157180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein-tyrosine kinases in cellular transformation.
    Varticovski L
    Sangre (Barc); 1991 Aug; 36(4):305-9. PubMed ID: 1663662
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein tyrosine kinases and cancer.
    Kolibaba KS; Druker BJ
    Biochim Biophys Acta; 1997 Dec; 1333(3):F217-48. PubMed ID: 9426205
    [No Abstract]   [Full Text] [Related]  

  • 10. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
    Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ
    Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing in on the biological functions of Fps/Fes and Fer.
    Greer P
    Nat Rev Mol Cell Biol; 2002 Apr; 3(4):278-89. PubMed ID: 11994747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HGF receptor family: unconventional signal transducers for invasive cell growth.
    Comoglio PM; Boccaccio C
    Genes Cells; 1996 Apr; 1(4):347-54. PubMed ID: 9135079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic receptors of class III receptor-type tyrosine kinases.
    Rosnet O; Birnbaum D
    Crit Rev Oncog; 1993; 4(6):595-613. PubMed ID: 7506935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
    Rossner MT; McArthur GA; Allen JD; Metcalf D
    Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein.
    Duronio V; Welham MJ; Abraham S; Dryden P; Schrader JW
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1587-91. PubMed ID: 1371879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functions of oncogene products.
    Hunter T
    Prog Clin Biol Res; 1989; 288():25-34. PubMed ID: 2541449
    [No Abstract]   [Full Text] [Related]  

  • 17. Tyrosine kinase signal transduction in rheumatoid synovitis.
    Williams WV; VonFeldt JM; Ramanujam T; Weiner DB
    Semin Arthritis Rheum; 1992 Apr; 21(5):317-29. PubMed ID: 1351318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms.
    Mancini A; Koch A; Wilms R; Tamura T
    J Biol Chem; 2002 Apr; 277(17):14635-40. PubMed ID: 11847211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'W' mutant forms of the Fms receptor tyrosine kinase act in a dominant manner to suppress CSF-1 dependent cellular transformation.
    Reith AD; Ellis C; Maroc N; Pawson T; Bernstein A; Dubreuil P
    Oncogene; 1993 Jan; 8(1):45-53. PubMed ID: 8380922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human colony-stimulating factor 1 (CSF-1) receptor confers CSF-1 responsiveness to interleukin-3-dependent 32DC13 mouse myeloid cells and abrogates differentiation in response to granulocyte CSF.
    Kato J; Sherr CJ
    Blood; 1990 May; 75(9):1780-7. PubMed ID: 1691932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.